Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Keller

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Autoimmunity Reviews|December 4, 2012
Chipping away at a mountain: genomic studies in common variable immunodeficiencyMichael D Keller, Soma Jyonouchi
Immunotargets and Therapy|June 9, 2016
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantationMichael D Keller, Catherine M Bollard
Blood|January 17, 2020
Virus-specific T-cell therapies for patients with primary immune deficiencyMichael D Keller, Catherine M Bollard
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 19, 2022
Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunityJessica R Durkee-Shock, Michael D Keller
Blood|March 3, 2022
Cellular therapies for the treatment and prevention of SARS-CoV-2 infectionSusan R Conway, Michael D Keller, Catherine M Bollard
The Israel Medical Association Journal : IMAJ|May 26, 2012
Severe malnutrition resulting from use of rice milk in food elimination diets for atopic dermatitisMichael D Keller, Michele Shuker, Jennifer Heimall, et al.
Frontiers in Immunology|April 5, 2018
Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency DisordersLauren P McLaughlin, Catherine M Bollard, Michael D Keller
Journal of the Pediatric Infectious Diseases Society|May 11, 2018
Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular MedicineMichael D Keller, Luigi D Notarangelo, Harry L Malech
Seminars in Hematology|April 20, 2023
Applications of virus-specific T cell therapies post-BMTCecilia M Motta, Michael D Keller, Catherine M Bollard
Transfusion|August 31, 2019
The pipeline of antiviral T-cell therapy: what's in the clinic and undergoing developmentAlyssa Fatic, Nan Zhang, Michael D Keller, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Autoimmunity Reviews|December 4, 2012
Chipping away at a mountain: genomic studies in common variable immunodeficiencyMichael D Keller, Soma Jyonouchi
Immunotargets and Therapy|June 9, 2016
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantationMichael D Keller, Catherine M Bollard
Blood|January 17, 2020
Virus-specific T-cell therapies for patients with primary immune deficiencyMichael D Keller, Catherine M Bollard
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 19, 2022
Immunizing the imperfect immune system: Coronavirus disease 2019 vaccination in patients with inborn errors of immunityJessica R Durkee-Shock, Michael D Keller
Blood|March 3, 2022
Cellular therapies for the treatment and prevention of SARS-CoV-2 infectionSusan R Conway, Michael D Keller, Catherine M Bollard
The Israel Medical Association Journal : IMAJ|May 26, 2012
Severe malnutrition resulting from use of rice milk in food elimination diets for atopic dermatitisMichael D Keller, Michele Shuker, Jennifer Heimall, et al.
Frontiers in Immunology|April 5, 2018
Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency DisordersLauren P McLaughlin, Catherine M Bollard, Michael D Keller
Journal of the Pediatric Infectious Diseases Society|May 11, 2018
Future of Care for Patients With Chronic Granulomatous Disease: Gene Therapy and Targeted Molecular MedicineMichael D Keller, Luigi D Notarangelo, Harry L Malech
Seminars in Hematology|April 20, 2023
Applications of virus-specific T cell therapies post-BMTCecilia M Motta, Michael D Keller, Catherine M Bollard
Transfusion|August 31, 2019
The pipeline of antiviral T-cell therapy: what's in the clinic and undergoing developmentAlyssa Fatic, Nan Zhang, Michael D Keller, et al.
Pageof 9